Scott D. Leigh

682 total citations
13 papers, 507 citations indexed

About

Scott D. Leigh is a scholar working on Molecular Biology, Oncology and Biomaterials. According to data from OpenAlex, Scott D. Leigh has authored 13 papers receiving a total of 507 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Biomaterials. Recurrent topics in Scott D. Leigh's work include Collagen: Extraction and Characterization (3 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Protein purification and stability (2 papers). Scott D. Leigh is often cited by papers focused on Collagen: Extraction and Characterization (3 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Protein purification and stability (2 papers). Scott D. Leigh collaborates with scholars based in United States, Germany and Netherlands. Scott D. Leigh's co-authors include David R. Olsen, Robert C. Chang, Stephen F. Carroll, Robert E. Williams, Richard A. Berg, P. David Toman, Ronald A. Hitzeman, Georgia Theofan, Hélène Gazzano-Santoro and George Chisholm and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Clinical Chemistry.

In The Last Decade

Scott D. Leigh

13 papers receiving 476 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scott D. Leigh United States 10 246 125 89 69 59 13 507
Neung‐Seon Seo United States 13 320 1.3× 58 0.5× 123 1.4× 80 1.2× 9 0.2× 19 599
Lin Wan China 17 465 1.9× 77 0.6× 144 1.6× 39 0.6× 5 0.1× 38 843
Adam C. Mirando United States 16 415 1.7× 62 0.5× 70 0.8× 29 0.4× 4 0.1× 23 636
Solmaz Sadeghi Iran 13 144 0.6× 44 0.4× 60 0.7× 39 0.6× 10 0.2× 22 397
Balajikarthick Subramanian United States 14 303 1.2× 214 1.7× 20 0.2× 65 0.9× 5 0.1× 19 662
Yanheng Wu China 14 233 0.9× 38 0.3× 169 1.9× 22 0.3× 25 0.4× 16 523
E. Móczár France 16 332 1.3× 43 0.3× 36 0.4× 95 1.4× 9 0.2× 73 661
Claudia Schöllmann Germany 11 245 1.0× 58 0.5× 43 0.5× 20 0.3× 6 0.1× 21 719
Junji Umemoto Japan 11 373 1.5× 12 0.1× 88 1.0× 27 0.4× 51 0.9× 15 616
Lalitha Ramanathapuram United States 15 416 1.7× 37 0.3× 247 2.8× 39 0.6× 34 0.6× 17 880

Countries citing papers authored by Scott D. Leigh

Since Specialization
Citations

This map shows the geographic impact of Scott D. Leigh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott D. Leigh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott D. Leigh more than expected).

Fields of papers citing papers by Scott D. Leigh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott D. Leigh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott D. Leigh. The network helps show where Scott D. Leigh may publish in the future.

Co-authorship network of co-authors of Scott D. Leigh

This figure shows the co-authorship network connecting the top 25 collaborators of Scott D. Leigh. A scholar is included among the top collaborators of Scott D. Leigh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott D. Leigh. Scott D. Leigh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Telikepalli, Srivalli, Michael J. Carrier, Dean C. Ripple, et al.. (2022). An Interlaboratory Study to Identify Potential Visible Protein-Like Particle Standards. AAPS PharmSciTech. 24(1). 18–18. 6 indexed citations
2.
Eichner, Daniel, Ryan M. Van Wagoner, James Chou, et al.. (2017). lmplementation of the prolyl hydroxylase inhibitor Roxadustat (FG‐4592) and its main metabolites into routine doping controls. Drug Testing and Analysis. 9(11-12). 1768–1778. 27 indexed citations
3.
Stroop, Steven D., et al.. (2011). Photosensitizers Form in Histidine Buffer and Mediate the Photodegradation of a Monoclonal Antibody. Journal of Pharmaceutical Sciences. 100(12). 5142–5155. 44 indexed citations
4.
Olsen, David R., Robert C. Chang, Robert J. Duffy, et al.. (2005). Expression and characterization of a low molecular weight recombinant human gelatin: development of a substitute for animal-derived gelatin with superior features. Protein Expression and Purification. 40(2). 346–357. 39 indexed citations
5.
Urquilla, P. R., Alan Yean Yip Fong, Scott D. Leigh, et al.. (2004). Upregulation of Endogenous Erythropoietin (EPO) in Healthy Subjects by Inhibition of Hypoxia Inducible Factor (HIF) Prolyl Hydroxylase.. Blood. 104(11). 174–174. 13 indexed citations
6.
Olsen, David R., Scott D. Leigh, Robert C. Chang, et al.. (2001). Production of Human Type I Collagen in Yeast Reveals Unexpected New Insights into the Molecular Assembly of Collagen Trimers. Journal of Biological Chemistry. 276(26). 24038–24043. 51 indexed citations
7.
Toman, P. David, George Chisholm, David R. Olsen, et al.. (2000). Production of Recombinant Human Type I Procollagen Trimers Using a Four-gene Expression System in the Yeast Saccharomyces cerevisiae. Journal of Biological Chemistry. 275(30). 23303–23309. 92 indexed citations
8.
Leigh, Scott D., et al.. (1998). Development of an immunoassay for urinary galactosylhydroxylysine. Journal of Immunological Methods. 220(1-2). 169–178. 8 indexed citations
9.
Wu, Hsiu‐Mei, Robert E. Williams, R. Little, et al.. (1997). Biochemical Characterization of Recombinant Fusions of Lipopolysaccharide Binding Protein and Bactericidal/Permeability-increasing Protein. Journal of Biological Chemistry. 272(4). 2149–2155. 54 indexed citations
10.
Brown, Bradley A., et al.. (1997). Comparison of analytical performance and biological variability of three bone resorption assays. Clinical Chemistry. 43(9). 1570–1576. 88 indexed citations
11.
Bauer, Robert J., Scott D. Leigh, C Birr, et al.. (1996). ALTERATION OF THE PHARMACOKINETICS OF SMALL PROTEINS BY IODINATION. Biopharmaceutics & Drug Disposition. 17(9). 761–774. 14 indexed citations
12.
Horwitz, Arnold H., Scott D. Leigh, Hélène Gazzano-Santoro, et al.. (1996). Expression and Characterization of Cysteine-Modified Variants of an Amino-Terminal Fragment of Bactericidal/Permeability-Increasing Protein. Protein Expression and Purification. 8(1). 28–40. 62 indexed citations
13.
Better, Marc, Susan L. Bernhard, Robert E. Williams, et al.. (1995). T Cell-targeted Immunofusion Proteins from Escherichia coli. Journal of Biological Chemistry. 270(25). 14951–14957. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026